Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Heparan sulfate: growth control with a restricted sequence menu
John T. Gallagher
John T. Gallagher
Published August 1, 2001
Citation Information: J Clin Invest. 2001;108(3):357-361. https://doi.org/10.1172/JCI13713.
View: Text | PDF
Perspective

Heparan sulfate: growth control with a restricted sequence menu

  • Text
  • PDF
Abstract

Authors

John T. Gallagher

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
The sulfated domains of HS are the main regions involved in the recognit...
The sulfated domains of HS are the main regions involved in the recognition of growth factors and other proteins. They are separated by flexible spacers of low sulfation. Although there is a vast potential for sequence diversity in the S-domains, the variation in any one cell type may be restricted as a result of the substrate specificities of the polymer-modifying enzymes that convert the precursor heparan (GlcA-GlcNAc)n to HS. Several proteins will bind to any individual S-domain, often by recognizing different structural features of the domain. Minimal sequences designed for binding exclusively to one protein are predicted to be rare but of major importance in cell biology. Evidence from animals deficient in HS-biosynthetic enzymes suggests that weak GAG-protein interactions may be more significant than was previously realized, and this has implications for understanding the mode of action of HS and for the design of HS/heparin mimetics.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts